MGNX: MacroGenics, Inc. Company Profile & Statistics

About

MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland.

Info & Links

CEO

Scott Koenig

Headquarters

9704 MEDICAL CENTER DRIVE
Rockville, MD 20850, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

339

MacroGenics, Inc. Statistics

Valuation Measures

Market Capitalization²

76.65M

Enterprise Value

-102.97M

Enterprise Value/EBITDA(ttm)

0.99

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.28

Price to Book(mrq)

1.50

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

86.85%

Operating Margin(ttm)

-69.07%

Profit Margin(ttm)

-366.93%

Return on Equity(ttm)

-89.42%

Return on Invested Capital(ttm)

-128.73%

Return on Assets(ttm)

-38.57%

Income Statement

Revenue(ttm)

141.33M

Revenue Per Share(ttm)

2.25

Gross Profit(ttm)

134.36M

EBITDA(ttm)³

-104.06M

Net Income Available to Common(ttm)

-97.62M

Diluted EPS(ttm)

-1.58

Share Statistics

Beta (5Y Monthly)

2.02

52-Week Change

-91.75%

S&P 500 52-Week Change

7.42%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

62.76M

Dividend Yield

0.00%

Float⁴

55.67M

% Held by Insiders

11.30%

% Held by Institutions

96.89%

Balance Sheet

Total Cash(mrq)

200.36M

Total Cash Per Share(mrq)

3.19

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.75%

Quick Ratio(mrq)

3.69%

Book Value Per Share(mrq)

1.91

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.48

Free Cash Flow(ytd)

-32.89M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

MGNX

MacroGenics, Inc.

MacroGenics, Inc. Profile